Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Oct;63(10):4034–4038. doi: 10.1128/iai.63.10.4034-4038.1995

Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic.

B Høgh 1, N T Marbiah 1, P A Burghaus 1, P K Andersen 1
PMCID: PMC173567  PMID: 7558316

Abstract

In areas where Plasmodium falciparum is endemic, immunoglobulin G is acquired by the fetus in utero, mainly during the third trimester of pregnancy. The potential protective effect of transferred anti-P. falciparum maternal antibodies was examined in a longitudinal study of 100 infants from birth to 1 year of age. The probability of acquiring a P. falciparum infection and developing an episode of clinical malaria was determined in relation to the P. falciparum-specific antibody level of the infant at birth against P. falciparum schizont antigen or recombinant merozoite surface protein MSP1(19) antigen. The risk of acquiring an episode of clinical malaria increased from birth to 6 months of age, after which it decreased. The overall prevalence of P. falciparum parasitemia was highest (48.9%) in the 6-month-old infants. The age-specific hematocrit value showed the lowest mean value (30.2) from 6 to 9 months, and the spleen rate was the highest (69.8%) at the same age. There was a lower risk of developing an episode of clinical malaria during the first year of life in the infants with high levels of anti-MSP1(19) antibodies at birth. The level of maternally derived overall anti-schizont antigen antibodies did not seem to play a role in the relative risk of developing malaria infection or disease during the first year of life, though the level of specific anti-MSP1(19) antibodies may be associated with protection.

Full Text

The Full Text of this article is available as a PDF (203.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asahi H., Kanazawa T. Continuous cultivation of intraerythrocytic Plasmodium falciparum in a serum-free medium with the use of a growth-promoting factor. Parasitology. 1994 Nov;109(Pt 4):397–401. doi: 10.1017/s0031182000080641. [DOI] [PubMed] [Google Scholar]
  2. BRUCE-CHWATT L. J. Malaria in African infants and children in Southern Nigeria. Ann Trop Med Parasitol. 1952 Sep;46(2):173–200. doi: 10.1080/00034983.1952.11685522. [DOI] [PubMed] [Google Scholar]
  3. Biggar R. J., Collins W. E., Campbell C. C. The serological response to primary malaria infection in urban Ghanaian infants. Am J Trop Med Hyg. 1980 Sep;29(5):720–724. doi: 10.4269/ajtmh.1980.29.720. [DOI] [PubMed] [Google Scholar]
  4. Blackman M. J., Heidrich H. G., Donachie S., McBride J. S., Holder A. A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med. 1990 Jul 1;172(1):379–382. doi: 10.1084/jem.172.1.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bryan J. H., Smalley M. E. The use of ABO blood groups as markers for mosquito biting studies. Trans R Soc Trop Med Hyg. 1978;72(4):357–360. doi: 10.1016/0035-9203(78)90127-x. [DOI] [PubMed] [Google Scholar]
  6. Burghaus P. A., Holder A. A. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol. 1994 Mar;64(1):165–169. doi: 10.1016/0166-6851(94)90144-9. [DOI] [PubMed] [Google Scholar]
  7. Campbell C. C., Martinez J. M., Collins W. E. Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador. Am J Trop Med Hyg. 1980 Mar;29(2):151–157. doi: 10.4269/ajtmh.1980.29.151. [DOI] [PubMed] [Google Scholar]
  8. Chappel J. A., Egan A. F., Riley E. M., Druilhe P., Holder A. A. Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro. Infect Immun. 1994 Oct;62(10):4488–4494. doi: 10.1128/iai.62.10.4488-4494.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Corkill J. A., Brabin B. J., MacGregor D. F., Alpers M. P., Milner R. D. Newborn splenic volumes vary under different malaria endemic conditions. Arch Dis Child. 1989 Apr;64(4):541–545. doi: 10.1136/adc.64.4.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Desowitz R. S. Plasmodium berghei: Enhanced Protective Immunity after Vaccination of White Rats Born of Immune Mothers. Science. 1971 Jun 11;172(3988):1151–1152. doi: 10.1126/science.172.3988.1151. [DOI] [PubMed] [Google Scholar]
  11. Egan A. F., Chappel J. A., Burghaus P. A., Morris J. S., McBride J. S., Holder A. A., Kaslow D. C., Riley E. M. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect Immun. 1995 Feb;63(2):456–466. doi: 10.1128/iai.63.2.456-466.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gammon G., Dunn K., Shastri N., Oki A., Wilbur S., Sercarz E. E. Neonatal T-cell tolerance to minimal immunogenic peptides is caused by clonal inactivation. 1986 Jan 30-Feb 5Nature. 319(6052):413–415. doi: 10.1038/319413a0. [DOI] [PubMed] [Google Scholar]
  13. Harte P. G., De Souza J. B., Playfair J. H. Failure of malaria vaccination in mice born to immune mothers. Clin Exp Immunol. 1982 Sep;49(3):509–516. [PMC free article] [PubMed] [Google Scholar]
  14. Hogh B., Marbiah N. T., Petersen E., Dolopaye E., Willcox M., Björkman A., Hanson A. P., Gottschau A. Classification of clinical falciparum malaria and its use for the evaluation of chemosuppression in children under six years of age in Liberia, west Africa. Acta Trop. 1993 Aug;54(2):105–115. doi: 10.1016/0001-706x(93)90056-h. [DOI] [PubMed] [Google Scholar]
  15. Holder A. A., Freeman R. R. The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J Exp Med. 1984 Aug 1;160(2):624–629. doi: 10.1084/jem.160.2.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MACDONALD G. The analysis of malaria parasite rates in infants. Trop Dis Bull. 1950 Oct;47(10):915–938. [PubMed] [Google Scholar]
  17. McElroy P. D., Beier J. C., Oster C. N., Beadle C., Sherwood J. A., Oloo A. J., Hoffman S. L. Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am J Trop Med Hyg. 1994 Nov;51(5):523–532. [PubMed] [Google Scholar]
  18. McGregor I. A., Rowe D. S., Wilson M. E., Billewicz W. Z. Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol. 1970 Jul;7(1):51–74. [PMC free article] [PubMed] [Google Scholar]
  19. Miller L. H., Roberts T., Shahabuddin M., McCutchan T. F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol. 1993 May;59(1):1–14. doi: 10.1016/0166-6851(93)90002-f. [DOI] [PubMed] [Google Scholar]
  20. Orjih A. U., Cochrane A. H., Nussenzweig R. S. Active immunization and passive transfer of resistance against sporozoite-induced malaria in infant mice. Nature. 1981 May 28;291(5813):331–332. doi: 10.1038/291331a0. [DOI] [PubMed] [Google Scholar]
  21. Pasvol G., Weatherall D. J., Wilson R. J. Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum. Nature. 1977 Nov 10;270(5633):171–173. doi: 10.1038/270171a0. [DOI] [PubMed] [Google Scholar]
  22. Riley E. M., Allen S. J., Wheeler J. G., Blackman M. J., Bennett S., Takacs B., Schönfeld H. J., Holder A. A., Greenwood B. M. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 1992 May;14(3):321–337. doi: 10.1111/j.1365-3024.1992.tb00471.x. [DOI] [PubMed] [Google Scholar]
  23. Sehgal V. M., Siddjiqui W. A., Alpers M. P. A seroepidemiological study to evaluate the role of passive maternal immunity to malaria in infants. Trans R Soc Trop Med Hyg. 1989;83 (Suppl):105–106. doi: 10.1016/0035-9203(89)90616-0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES